Although monoclonal antibodies have been applied to targeted CEUS molecular imaging over ten years [24–26], it is not known whether SHP2 can serve as a new molecular marker for thyroid tumour detection using ultrasound imaging. This evidence concerns the gene PTPN11 and thyroid tumor.